A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
NCT06638307
This study is recruiting at 37 US sites in 20 states, according to its ClinicalTrials.gov record last updated .
Summary
This is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KAT6) inhibitor, in adult participants with advanced breast cancer.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Advanced Breast Cancer
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Stemline Therapeutics, Inc.
- Last updated on ClinicalTrials.gov
- August 7, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arkansas · 1
- Highlands Oncology Group · Springdale, AR
California · 5
- City of Hope · Duarte, CA
- UC San Diego Moores Cancer Center · La Jolla, CA
- Stanford Cancer Center · Palo Alto, CA
- UCSF Helen Diller Family Comprehensive Cancer Center · San Francisco, CA
- UCLA Hematology Oncology - Parkside · Santa Monica, CA
Connecticut · 1
- Yale Comprehensive Cancer Center · New Haven, CT
Florida · 4
- Advent Health Orlando · Altamonte Springs, FL
- Sarah Cannon Research Institute at Florida Cancer Specialists · Orlando, FL
- Florida Cancer Specialists & Research Institute (FCS) - Sarasota · Sarasota, FL
- Moffitt Cancer Center · Tampa, FL
Georgia · 1
- Winship Cancer Institute, Emory University · Atlanta, GA
Illinois · 2
- University of Chicago Medical Center · Chicago, IL
- University of Illinois Hospital and Health Sciences System (Outpatient Cancer Center) · Chicago, IL
Iowa · 1
- University of Iowa Health Care · Iowa City, IA
Kansas · 1
- The University of Kansas Cancer Center · Fairway, KS
Maryland · 1
- Sidney Kimmel Comprehensive Cancer Center · Baltimore, MD
Massachusetts · 2
- Dana-Farber Cancer Institute · Boston, MA
- Massachusetts General Hospital Cancer Center · Boston, MA
Michigan · 1
- START Midwest - Oncology · Grand Rapids, MI
Minnesota · 1
- Mayo Clinic · Rochester, MN
New Jersey · 1
- Astera Cancer Care · East Brunswick, NJ
New York · 4
- Perlmutter Cancer Center - Sunset Park · Brooklyn, NY
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island · Mineola, NY
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health · New York, NY
- Memorial Sloan Kettering Cancer Center · New York, NY
Oregon · 1
- Providence Cancer Institute Franz Clinic · Portland, OR
Tennessee · 2
- The West Clinic, PC dba West Cancer Center · Germantown, TN
- SCRI Oncology Partners Group · Nashville, TN
Texas · 4
- University of Texas Southwestern Medical Center · Dallas, TX
- The University of Texas M.D. Anderson Cancer Center · Houston, TX
- START San Antonio, LLC · San Antonio, TX
- University of Texas Health Science Center San Antonio · San Antonio, TX
Utah · 1
- START Mountain · West Valley City, UT
Virginia · 1
- NEXT Virginia · Fairfax, VA
Wisconsin · 2
- University of Wisconsin Carbone Cancer Center · Madison, WI
- Froedtert Hospital & the Medical College of Wisconsin · Milwaukee, WI
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.